Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol/Dydrogesterone vs Tibolone in Postmenopausal Women
NCT00145522Phase 4Completed
- Sponsor
- Solvay
- Start
- Nov 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol + dydrogesterone in menopause (2 arms), sponsored by Solvay. Primary endpoint: Insulin-like Growth Factor-1 at 1 year. Started Nov 2005; status: completed.
02
Drugs
estradiol + dydrogesterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00145522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145522.